Since cathepsins are also overexpressed in colorectal cancer, brain cancer, lung cancer, ovarian cancer, and soft tissue sarcoma [11, 45], VGT-309 can be considered for tumor delineation and resection in many different types of cancers. The gene discussed is CTSS; the disease is brain cancer.